SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-033320
Filing Date
2020-06-01
Accepted
2020-06-01 21:42:54
Documents
1
Period of Report
2020-05-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6563
  Complete submission text file 0001209191-20-033320.txt   7970
Mailing Address 21823 30TH DRIVE SE BOTHELL WA 98021
Business Address
DRACHMAN JONATHAN G (Reporting) CIK: 0001588467 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38800 | Film No.: 20935477

Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Issuer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)